Tri-legest fe side effects, by duration, gender and age (a phase IV clinical study of FDA data)
Summary:
Side effects are reported by people who take Tri-legest fe (ethinyl estradiol; norethindrone acetate). Common side effects include acne among females.
The phase IV clinical study is created by eHealthMe based on 25 reports from the FDA, and is updated regularly.
What is Tri-Legest Fe?
Tri-legest fe has active ingredients of ethinyl estradiol; norethindrone acetate. It is often used in birth control. eHealthMe is studying from 44 Tri-legest fe users. Check the latest studies of Tri-legest fe.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
25 people who take Tri-Legest Fe and have side effects are studied.

What are the common side effects of Tri-Legest Fe, by gender? *:
female:
- Acne (skin problems that cause pimples)
- Alopecia (absence of hair from areas of the body)
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Dehydration (dryness resulting from the removal of water)
- Haemorrhage (bleeding)
- Headache (pain in head)
- Metrorrhagia (uterine bleeding at irregular intervals)
- Pharyngitis (inflammation of the pharynx, causing a sore throat)
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
male:
n/a
What are the common side effects of Tri-Legest Fe, by age (0-1 to 60+) *:
0-1:
n/a
2-9:
n/a
10-19:
- Adverse drug reaction
- Alopecia (absence of hair from areas of the body)
20-29:
- Activities of daily living impaired
- Alopecia (absence of hair from areas of the body)
- Anxiety
30-39:
n/a
40-49:
- Acne (skin problems that cause pimples)
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Metrorrhagia (uterine bleeding at irregular intervals)
50-59:
n/a
60+:
n/a
What are the common side effects of Tri-Legest Fe, by the time people have been on the drug (< 1 month to 10+ years)? *:
< 1 month:
- Adverse drug reaction
1 - 6 months:
n/a
6 - 12 months:
n/a
1 - 2 years:
n/a
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
- Acne (skin problems that cause pimples)
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Dehydration (dryness resulting from the removal of water)
- Dizziness
- Haemorrhage (bleeding)
- Headache (pain in head)
- Metrorrhagia (uterine bleeding at irregular intervals)
- Pharyngitis (inflammation of the pharynx, causing a sore throat)
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Alopecia (absence of hair from areas of the body)
* Approximation only. Some reports may have incomplete information.
Do you take Tri-legest fe?
- Personalize this study to your gender and age- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
How the study uses the data?
The study is based on ethinyl estradiol; norethindrone acetate (the active ingredients of Tri-legest fe) and Tri-legest fe (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies are listed below in case you need more information:
Alternative drugs to, pros and cons of Tri-legest fe:
- Tri-legest fe (44 reports)
All Tri-legest fe side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Morphine cause Anion Gap Increased? - a second ago
- Could Movantik cause Back Pain? - 3 seconds ago
- Could Chlorhexidine Gluconate cause Cervical Spinal Stenosis? - 7 seconds ago
- Drug interactions of Dipyridamole and Amoxicillin - 8 seconds ago
- Could Mitomycin cause Back Pain? - 14 seconds ago
- Drug interactions of Zyrtec and Premphase - 19 seconds ago
- Could Metoprolol Tartrate cause Full Blood Count Decreased? - 19 seconds ago
- Drug interactions of Faslodex and Tylenol - 27 seconds ago
- Drug interactions of Methocarbamol and Metoprolol Succinate - 28 seconds ago
- Drug interactions of Baclofen and Caffeine - 33 seconds ago